Month: September 2026

For patients facing kidney surgery, the phrase future robotic kidney surgery can suggest a major change in what an operation will involve. Some advances are already part of established specialist practice, while others remain promising technologies being assessed for safety, accuracy and meaningful benefit. The central aim is unlikely to change: treat the kidney condition effectively while preserving kidney function and supporting a safe recovery.

Robotic kidney surgery today

Robotic surgery is already used for selected kidney procedures, particularly robotic partial nephrectomy and robotic nephrectomy. In a partial nephrectomy, the surgeon removes a tumour or abnormal area while preserving as much healthy kidney tissue as possible. A nephrectomy involves removal of all or part of a kidney when this is the safest treatment option.

The robotic system does not perform surgery independently. It is controlled directly by the surgeon from a console in the operating theatre. It provides a magnified three-dimensional view and wristed instruments that can allow precise movements through small incisions. For suitable patients, this minimally invasive approach may reduce wound size and support an earlier return to usual activities compared with an open operation.

Robotic access is not automatically the best choice for every kidney operation. The location and size of a tumour, its relationship to blood vessels and the collecting system, previous abdominal surgery, body habitus, kidney function and overall health all affect surgical planning. In some cases, open surgery remains the most appropriate and safest approach.

Why kidney preservation is a priority

The future of robotic kidney surgery will be shaped by the increasing focus on nephron preservation. Nephrons are the filtering units within the kidney. When clinically appropriate, preserving healthy kidney tissue can help maintain long-term renal function, particularly for people with reduced kidney function, diabetes, high blood pressure, a solitary kidney or disease affecting both kidneys.

Partial nephrectomy is technically demanding. The surgeon may need to control blood flow to the kidney temporarily, remove the lesion with an appropriate margin, repair the kidney and ensure that the collecting system is closed if entered. The operation must balance cancer control, bleeding risk, preservation of functioning tissue and protection of the kidney from prolonged interruption to its blood supply.

Robotic technology can assist with the precision required for this work. However, outcomes depend on far more than the platform. Careful imaging review, appropriate case selection, surgical judgement, anaesthetic care and post-operative follow-up remain fundamental.

Future robotic kidney surgery and better planning

One of the most practical areas of development is pre-operative planning. CT and MRI scans already provide detailed information about kidney anatomy and kidney masses. Future systems may make it easier to convert these images into patient-specific three-dimensional models that surgeons can review before surgery.

This may be especially useful when a tumour is close to major vessels or deep within the kidney. A detailed model could help identify the safest route to the lesion, estimate how much kidney tissue may be preserved and anticipate whether the collecting system is likely to require repair.

The value of this technology will depend on whether it improves clinical decisions rather than simply producing more detailed images. A three-dimensional reconstruction cannot replace review of the original scans or the surgeon’s assessment. It may, however, provide another useful planning tool for selected complex procedures.

Imaging during the operation

Intra-operative ultrasound and fluorescence imaging are also likely to have an increasing role. Ultrasound can help define a lesion that is not obvious on the kidney surface. Fluorescence techniques may assist in assessing blood flow and distinguishing anatomical structures in particular cases.

These technologies need to be interpreted in context. They do not provide a universal map of every tumour and are not required for every operation. Their benefit is most likely when they answer a specific surgical question, such as confirming the depth of a mass or checking perfusion after reconstruction.

The role of artificial intelligence

Artificial intelligence may eventually support the analysis of scans, identification of anatomical features and prediction of surgical complexity. For example, software may help measure tumour characteristics, estimate the likelihood of a collecting-system entry or identify patients who require additional assessment before surgery.

There are important limits. Algorithms are only as reliable as the data used to develop them, and performance can vary between hospitals, scanners and patient groups. AI should support clinical decision-making, not determine it. A surgeon remains responsible for interpreting imaging, discussing treatment options and responding to findings during the operation.

Patient privacy and clinical governance will also be central. Any digital system used in surgical care must be appropriately validated, securely managed and shown to improve care in the setting where it is used.

Smaller access and improved instruments

Future robotic platforms may offer slimmer instruments, improved camera systems and greater flexibility in port placement. Some systems are being developed to allow surgery through fewer incisions. These changes may improve access in selected operations and reduce the impact of incisions for some patients.

Smaller access is not the same as better surgery. The priority is adequate exposure and control of critical structures, particularly the kidney vessels and ureter. An operation should not be made more technically difficult solely to reduce the number of ports. The safest approach is the one that provides the surgeon with the access needed to complete the procedure accurately.

Further refinements may include better instrument feedback and improved ergonomics for the surgical team. Traditional robotic systems do not provide the same direct tactile sensation as open surgery. Surgeons instead rely on visual cues and experience. Technologies that improve force sensing or visual information may assist, although they will need to demonstrate a genuine benefit in clinical practice.

Training, experience and access to care

As robotic kidney surgery develops, specialist training remains essential. New systems and techniques require structured training, proctorship where appropriate, ongoing assessment and a clear understanding of when a conventional laparoscopic or open operation is preferable.

For South Australian patients, access also involves more than the technology itself. Complex kidney surgery requires suitable hospital facilities, experienced theatre and anaesthetic teams, pathology services and follow-up close to home where possible. Patients from regional areas may need a plan that coordinates specialist assessment, surgery and local post-operative care.

Robotic technology may also support education through recorded procedures, simulation and expert mentoring. Remote guidance has potential in carefully controlled settings, but it does not remove the need for an appropriately credentialled surgical team present with the patient. Fully remote or autonomous kidney surgery is not a routine clinical reality and should not be viewed as the immediate direction of care.

What patients should ask about a robotic approach

A discussion about robotic surgery should begin with the condition being treated, not with the machine. For a kidney mass, patients should understand whether active surveillance, biopsy, partial nephrectomy, radical nephrectomy, ablation or another pathway is appropriate. The answer depends on the imaging findings, suspected diagnosis, growth pattern, kidney function and individual health circumstances.

Where surgery is recommended, useful questions include whether kidney-preserving surgery is feasible, the expected risks of bleeding or urine leak, the possibility of conversion to an open operation, and how the procedure may affect kidney function. It is also reasonable to ask about the surgeon’s experience with the proposed operation and the hospital setting in which it will be performed.

A robotic operation can offer important advantages for suitable patients, but it remains one component of a carefully planned treatment pathway. The right procedure is the one that gives the best balance of disease control, kidney preservation and surgical safety for the individual patient.

For anyone considering kidney surgery, a specialist consultation provides the opportunity to review the scans, discuss the available surgical and non-surgical options, and make decisions based on current evidence rather than future promise alone.

A PSA result is not a diagnosis. It is one piece of clinical information that can help identify men who may need further assessment for prostate cancer or other prostate conditions. So, is PSA test accurate? It is useful, but it is not precise enough to confirm or exclude cancer on its own.

PSA testing is most valuable when the result is interpreted in context: your age, prostate size, urinary symptoms, family history, medications, previous PSA results and examination findings all matter. A single raised reading should prompt a considered discussion, not immediate assumptions.

What the PSA test measures

PSA stands for prostate-specific antigen, a protein produced by prostate cells. A small amount normally circulates in the bloodstream and can be measured with a blood test. PSA levels often rise as the prostate enlarges with age, but they can also increase when the prostate is inflamed, infected or affected by cancer.

The test does not measure cancer directly. It measures a prostate-derived protein that can be elevated for several different reasons. This is why PSA is best regarded as a screening and risk-assessment tool rather than a definitive cancer test.

A low PSA result reduces the likelihood of clinically significant prostate cancer, but it does not make the risk zero. Conversely, a raised PSA does not necessarily mean cancer is present. Many men with an elevated result have benign prostate enlargement or a temporary cause for the increase.

Is PSA test accurate for prostate cancer?

The accuracy of a PSA test depends on what question is being asked. It can identify men who may have a higher risk of prostate cancer and who could benefit from further investigation. However, it cannot reliably distinguish between cancer, benign enlargement and inflammation.

For this reason, PSA has two recognised limitations. It can produce a false-positive result, where PSA is raised but no cancer is found. It can also produce a false-negative result, where PSA is within an expected range despite cancer being present. Neither outcome means the test has failed; rather, it reflects that PSA is influenced by more than one condition.

PSA is generally more informative when measured over time. A stable result may be reassuring, while a persistent rise or a significant change from your usual level may warrant closer review. The pattern is not interpreted in isolation, as short-term variation can occur between tests.

There is no single PSA number that applies to every man. A level that is concerning in a younger man with a smaller prostate may be less concerning in an older man with marked benign enlargement. Specialist assessment considers the individual rather than relying only on a laboratory reference range.

Factors that can raise PSA without cancer

Several common circumstances may raise PSA temporarily or persistently. Benign prostatic hyperplasia, often called an enlarged prostate, is a frequent cause. Prostatitis and urinary tract infection can also lead to substantial PSA elevation.

Recent ejaculation, vigorous cycling, urinary retention and instrumentation of the urinary tract may affect results in some men. A catheter, cystoscopy or prostate procedure can alter PSA levels, and testing may need to be timed appropriately after these events. It is sensible to tell your GP or urologist about recent illness, urinary symptoms and procedures before arranging or interpreting the blood test.

Some medicines can lower PSA. In particular, medications used to treat benign prostate enlargement, such as finasteride or dutasteride, may reduce the measured PSA level. The result can still be clinically useful, but the prescribing doctor needs to account for the medication when assessing it.

Why repeat testing is often appropriate

When PSA is unexpectedly raised, repeating the blood test is commonly the first step. This can help determine whether the increase persists once temporary factors, infection or laboratory variation have been considered. If there are symptoms of infection, these should be assessed and managed before relying on a PSA result for cancer risk assessment.

Repeating a test is not a delay in care. It is often the safest way to avoid unnecessary invasive investigation while ensuring an important rise is not overlooked. The interval and approach depend on the PSA level, symptoms, examination findings and individual risk factors.

Men with a father or brother diagnosed with prostate cancer, particularly at a younger age, may have a higher risk. Risk can also be increased by certain inherited genetic changes. In these circumstances, PSA monitoring may begin earlier or be undertaken more regularly following discussion with a doctor.

How a raised PSA is investigated

If PSA remains elevated or the overall risk is concerning, the next step is not automatically a biopsy. A urologist may review your PSA history, urinary symptoms, medications and family history, and perform a digital rectal examination where appropriate. This examination assesses the prostate for features such as enlargement, asymmetry or a firm area.

Multiparametric MRI of the prostate is now an important part of assessing many men with a raised PSA. MRI can identify areas that may need targeted sampling and can help some men avoid biopsy where the scan is reassuring and their overall risk is low. An MRI result must still be considered alongside PSA density, which relates the PSA level to prostate volume, and other clinical findings.

When a biopsy is recommended, it is because the available information suggests that tissue assessment is needed to clarify whether cancer is present and, if so, how significant it may be. Modern biopsy techniques aim to sample suspicious areas identified on MRI as well as other parts of the prostate where necessary. As with any procedure, biopsy has potential risks, including bleeding, infection and temporary urinary symptoms, which should be discussed in advance.

What PSA can and cannot tell you

PSA can help identify a risk that deserves further assessment. It can assist with monitoring after prostate cancer treatment and may be used alongside imaging and examination when evaluating prostate symptoms. It is particularly useful when compared with previous results under similar testing conditions.

It cannot tell you with certainty whether you have prostate cancer. It also cannot establish the grade or extent of a cancer, and it cannot determine whether treatment is required. Some prostate cancers are slow growing and may be monitored, while others need active treatment. Those decisions rely on biopsy findings, imaging, general health and personal priorities, not PSA alone.

A normal PSA should not be used to dismiss persistent symptoms such as blood in the urine, recurrent urinary infection, unexplained weight loss, new bone pain or significant changes in urinary function. These symptoms are often caused by conditions other than prostate cancer, but they still require appropriate medical review.

Who should consider a PSA test?

PSA testing is a personal decision that should follow an informed discussion with a GP or urologist. It is most commonly considered for men aged 50 to 69, and may be considered earlier for men with a significant family history of prostate cancer or other recognised risk factors.

The potential benefit is earlier detection of clinically significant cancer. The trade-off is that testing can lead to anxiety, further scans or biopsy, and detection of low-risk cancers that may never have caused harm. These are not reasons to avoid the conversation. They are reasons to make the decision with clear information about your circumstances.

If you have lower urinary tract symptoms such as a weak stream, frequency, urgency or getting up repeatedly overnight, a PSA test may be one part of the assessment. These symptoms are commonly related to benign prostate enlargement and do not, by themselves, indicate cancer.

Preparing for a more reliable PSA result

Before testing, ask whether you should delay the blood test if you have a suspected urinary infection, recent urinary retention or a recent prostate procedure. Avoiding ejaculation and strenuous cycling for 24 to 48 hours beforehand may also reduce the chance of a temporary rise. Use the same laboratory where possible when comparing results, as methods can vary slightly.

Most importantly, ensure the clinician interpreting the result knows about medications, previous PSA readings and any recent changes in your urinary health. A number on a pathology report is far less useful without that clinical context.

A PSA test is neither a verdict nor a guarantee. It is a practical starting point for an informed discussion about prostate health, with further assessment guided by your individual risk rather than fear of a single result.

A weak stream, repeated night-time trips to the bathroom and the feeling that the bladder never quite empties can gradually restrict work, travel and sleep. For men whose symptoms are caused by benign enlargement of the prostate, laser prostatectomy is one surgical option designed to remove or reduce obstructing prostate tissue and improve urine flow.

The term can sound broad, and it is. Several laser techniques are used in contemporary urology, with the most suitable approach depending on prostate size, anatomy, medical history, medicines and the severity of urinary obstruction. A specialist assessment is needed to establish whether surgery is appropriate and, if it is, which procedure offers the best balance of symptom relief, recovery and risk.

What is laser prostatectomy?

Laser prostatectomy generally refers to an operation that uses laser energy to treat benign prostatic enlargement, also called benign prostatic hyperplasia or BPH. The prostate sits below the bladder and surrounds the urethra, the channel that carries urine out of the body. As the prostate enlarges with age, it can narrow that channel and make bladder emptying difficult.

During the procedure, a telescope is passed through the urethra. There are no external cuts. The laser is used either to remove obstructing tissue from the inner part of the prostate or to vaporise it. The removed tissue may be fragmented and taken out through the telescope, depending on the technique used.

Laser prostatectomy for urinary symptoms is different from a radical prostatectomy, which removes the whole prostate as treatment for prostate cancer. The purpose of laser treatment for BPH is to create a wider urinary channel while leaving the outer part of the prostate in place.

When may laser treatment be considered?

Medication is often the first treatment for bothersome symptoms caused by an enlarged prostate. Medicines can relax the prostate or reduce its size over time, but they do not suit everyone and may not adequately address significant blockage.

Surgery may be considered when symptoms remain disruptive despite medication, when a patient cannot tolerate medication, or when obstruction is affecting bladder or kidney function. It may also be recommended after recurrent urinary retention, repeated urinary infections associated with poor emptying, bladder stones, blood in the urine thought to arise from the prostate, or a persistently high residual volume of urine in the bladder.

Symptoms alone do not confirm that prostate enlargement is the cause. Similar problems can arise from bladder dysfunction, urethral narrowing, infection, stones or, less commonly, cancer. Careful investigation is therefore essential before deciding on treatment.

Assessment before surgery

A urological consultation usually includes discussion of urinary symptoms, current medications, medical conditions and previous surgery. Assessment may involve a urine test, blood tests including prostate-specific antigen where appropriate, examination of the prostate, urinary flow testing and an ultrasound measurement of urine left in the bladder after voiding.

Some patients require a cystoscopy, in which a fine telescope is used to inspect the urethra, prostate and bladder. Imaging or specialised bladder pressure testing may also be useful in selected cases. These tests help determine whether the prostate is obstructing flow and whether the bladder has sufficient function to benefit from surgery.

Laser enucleation and laser vaporisation

The two main concepts in laser prostate surgery are enucleation and vaporisation. Both aim to relieve obstruction, but they do so differently.

Laser enucleation separates the enlarged inner prostate tissue from its outer capsule. The tissue is moved into the bladder, broken into smaller pieces and removed. Holmium laser enucleation of the prostate, often called HoLEP, is one example. Because the obstructing tissue is comprehensively removed, enucleation can be particularly useful for larger prostates and provides tissue that can be sent for laboratory examination.

Laser vaporisation directs laser energy at the obstructing tissue to remove it progressively by vaporising it. GreenLight laser treatment is a commonly recognised example. It can be effective for appropriately selected prostates, although the amount of tissue that can be treated efficiently and the expected durability may vary with prostate size and the technique used.

There is no single laser procedure that is best for every patient. Prostate size matters, but it is not the only consideration. A man taking blood-thinning medication, with a urinary catheter due to retention, or with significant medical conditions may require a different operative plan from someone with moderate symptoms and a smaller prostate.

What happens on the day of surgery?

Laser prostate surgery is performed in hospital under anaesthetic. The surgical team passes the operating telescope through the urethra and treats the obstructing tissue under direct vision. The procedure length varies according to the prostate size and the technique required.

At the end of surgery, a urinary catheter is usually placed to drain urine and allow bladder irrigation if needed. It is common for urine to be pink or blood-stained initially. The catheter is often removed the following day, although some patients need it for longer, particularly after treatment of a large prostate or where bladder function has been reduced by longstanding obstruction.

Many patients go home after an overnight stay, while some may be suitable for discharge on the day of surgery. The appropriate length of stay depends on the operation, bleeding risk, other health conditions and how well the bladder is emptying after catheter removal.

Recovery after laser prostatectomy

Improvement in urinary flow may be noticeable soon after surgery, but recovery is not always immediate. The bladder can take time to adjust after months or years of working against obstruction. Frequency, urgency and mild burning when passing urine can occur in the first weeks and generally settle progressively.

Drinking adequate water is usually encouraged unless there is another medical reason to limit fluids. Small amounts of blood in the urine, particularly after increased activity, can occur while the treated area heals. Patients are commonly advised to avoid heavy lifting, strenuous exercise and activities that strain the pelvic area for several weeks. The specific timeframe should be confirmed with the treating surgeon.

Passing small fragments or debris in the urine may occur after some procedures. Constipation should be avoided, as straining can worsen discomfort and bleeding. A temporary change in urinary control can occur following surgery, particularly after extensive tissue removal. For most men this improves as healing progresses, but it should be discussed before treatment as individual risk varies.

Benefits and limitations to discuss

The principal benefit of laser surgery is relief of prostate-related obstruction without an external incision. Laser techniques can offer good visual control during surgery and may reduce bleeding compared with some traditional operations. This can be relevant for patients with medical conditions that increase bleeding risk, although blood-thinning medicines must never be stopped or altered without advice from the prescribing doctor and surgical team.

Laser enucleation can treat a wide range of prostate sizes and is designed to give durable relief by removing the tissue responsible for obstruction. However, it is a technically specialised procedure and availability depends on surgeon training, equipment and hospital facilities.

No operation can guarantee that every urinary symptom will resolve. Surgery improves symptoms caused by obstruction, but it does not directly correct an overactive or poorly functioning bladder. Men with severe urgency, frequent urination or bladder damage may have residual symptoms even when the urinary channel is successfully widened.

Risks of laser prostate surgery

All surgery carries potential risks. With laser prostatectomy, these include bleeding, urinary infection, temporary difficulty passing urine after catheter removal, burning or urgency during recovery, and the need for further treatment if obstruction recurs or residual tissue remains.

Less common risks include urethral stricture, scarring at the bladder outlet, injury to the bladder and persistent urinary leakage. Fluid absorption problems are uncommon with modern laser techniques but remain part of the broader operative discussion. Anaesthetic risks also need to be considered in the context of each patient’s general health.

Before proceeding, the surgeon should explain the proposed technique, expected outcomes, alternatives and the risks most relevant to the individual. This discussion is especially important for men with prior prostate procedures, neurological conditions, large bladder diverticula, kidney impairment or complex medication needs.

Choosing the right treatment pathway

Laser prostatectomy is one option within a broader range of treatments for enlarged prostate symptoms. In some cases, medication and monitoring remain appropriate. In others, alternative endoscopic procedures or surgery may be more suitable based on prostate anatomy, gland size, bleeding risk and access to particular technology.

At Urology Health Adelaide, assessment is centred on identifying the cause of urinary symptoms first, then recommending a procedure only where the expected benefit is clear. For men in Adelaide and regional South Australia, timely specialist review can clarify whether symptoms are due to an enlarged prostate and whether laser treatment is a sensible next step.

Persistent changes in urine flow, recurrent retention, visible blood in the urine or repeated urinary infections warrant medical review rather than self-management. A clear diagnosis and an individualised surgical plan provide the best basis for restoring comfortable, reliable bladder emptying.

A hydrocele can become difficult to ignore when the swelling makes walking, exercise, work, or wearing fitted clothing uncomfortable. Hydrocele surgery is a reliable treatment for adults with a persistent or troublesome hydrocele, particularly when it is increasing in size or affecting day-to-day comfort.

A hydrocele is a collection of fluid around the testicle, within the scrotum. It commonly causes painless swelling on one side of the scrotum, although the size and sensation can vary. Some men describe a feeling of heaviness, dragging, or pressure rather than pain. While hydroceles are usually benign, a new scrotal swelling should be assessed by a doctor or urologist to confirm the diagnosis and exclude other causes.

When is hydrocele surgery recommended?

Not every hydrocele requires treatment. A small, stable hydrocele that is not causing discomfort can often be monitored. Surgery is usually considered when swelling is persistent, enlarging, uncomfortable, cosmetically concerning, or making physical activity difficult.

In adults, a hydrocele may occur without an obvious cause, but it can also develop after inflammation, infection, injury, previous surgery, or another condition affecting the scrotum. The priority is to establish whether the swelling is truly a hydrocele and whether there is an underlying issue requiring separate treatment.

A specialist consultation generally includes a medical history and examination of the scrotum and testicles. An ultrasound may be arranged if the diagnosis is uncertain, if the testicle cannot be examined properly because of fluid, or if there are features that need further assessment. This imaging uses sound waves and does not involve radiation.

Symptoms that need prompt assessment

A hydrocele is commonly painless, so sudden or severe pain should not simply be assumed to be due to the fluid collection. Urgent medical assessment is appropriate for sudden scrotal pain, rapid swelling, fever, redness, nausea, or a new hard lump in the testicle. These symptoms may indicate a different condition that needs timely treatment.

What happens during hydrocele surgery?

The operation to treat a hydrocele is called a hydrocelectomy. It is performed in hospital, usually as a day procedure under a general anaesthetic. In some circumstances, an overnight stay may be appropriate depending on the operation, anaesthetic requirements, other health conditions, and recovery after surgery.

The surgeon makes a small incision in the scrotum to access the sac containing the fluid. The fluid is drained, and the sac is then removed or reshaped so it is less likely to refill. The specific technique depends on the size and nature of the hydrocele, the thickness of the sac, and the surrounding anatomy.

The incision is closed with sutures, often dissolvable sutures. A dressing and supportive underwear are usually applied at the end of the procedure. Occasionally, a temporary drain may be used where there is a greater risk of fluid or blood collecting after surgery. If a drain is required, the surgical team will explain how and when it will be removed.

Hydrocele surgery is different from needle aspiration, where fluid is drained using a needle. Aspiration can provide short-term relief for selected patients but the fluid commonly returns, and there is a risk of infection. For a fit patient with a symptomatic hydrocele, hydrocelectomy generally provides a more definitive result.

Preparing for a hydrocelectomy

Before surgery, patients receive instructions about fasting, medications, and arrival time at hospital. Blood-thinning medicines, including some prescribed anticoagulants and antiplatelet medicines, may need specific management. This should only be done under direction from the prescribing doctor, surgeon, or anaesthetist.

It is helpful to arrange transport home and for someone to be available on the first night after a general anaesthetic. Loose clothing and supportive briefs are usually more comfortable than loose boxer shorts in the first days after surgery.

Smoking can increase the risk of wound problems and delayed healing. If possible, stopping smoking before an operation is beneficial. Diabetes, heart or lung conditions, sleep apnoea, and previous reactions to anaesthesia should also be discussed during pre-operative assessment.

Recovery after hydrocele surgery

Scrotal swelling and bruising are expected after hydrocele surgery. In fact, the scrotum may look more swollen initially than some patients expect. This early swelling does not necessarily mean the hydrocele has returned. It can take several weeks, and occasionally longer, for the tissues to settle and for the final appearance to become clear.

Pain is usually manageable with prescribed or over-the-counter pain relief as advised by the treating team. A scrotal support, rest, and intermittent cold packs wrapped in cloth can help limit discomfort and swelling during the first 24 to 48 hours. Avoid placing ice directly on the skin.

Most patients can walk gently soon after surgery and resume light activities within a few days. The timing for return to work depends on the nature of the work and the individual recovery. Desk-based work may be possible after several days, while physically demanding work, heavy lifting, cycling, running, and gym training generally need to wait longer. Sexual activity should also be avoided until the wound has healed and discomfort has settled, commonly for around two to four weeks.

Showering is often permitted after a short period, but patients should follow their surgeon’s specific wound-care advice. Baths, swimming pools, and spas should be avoided until the incision is fully healed. If the dressing becomes wet, loose, or heavily stained, contact the surgical team for guidance.

When to contact your surgeon

Some bruising, mild oozing, and tenderness can be part of normal recovery. However, increasing pain, spreading redness, fever, offensive wound discharge, difficulty passing urine, rapidly enlarging swelling, or persistent bleeding should be reviewed promptly. These can be signs of infection, haematoma, or another post-operative issue.

A follow-up appointment allows the wound, swelling, and recovery to be assessed. It is also an opportunity to discuss any concerns about return to exercise, work, travel, or ongoing scrotal discomfort.

Risks and expected outcomes of hydrocele surgery

Hydrocelectomy is a commonly performed scrotal procedure, but all surgery involves some risk. The most relevant risks include bleeding or a blood collection in the scrotum, infection, prolonged swelling, fluid recurrence, wound separation, and persistent discomfort. Less commonly, there can be injury to nearby structures, including the testicle or its blood supply.

The risk profile differs between patients. A very large hydrocele, previous scrotal surgery, use of blood-thinning medication, medical conditions affecting healing, and the presence of inflammation can all influence the procedure and recovery. A urologist can explain the likely benefits and the risks relevant to the individual situation.

Most patients experience a substantial improvement in the heaviness and swelling caused by the hydrocele. However, recovery should be judged over weeks rather than days. Early swelling is common, and allowing adequate time before returning to strenuous activity can reduce the chance of setbacks.

Choosing specialist assessment for scrotal swelling

Scrotal swelling has several possible causes, and a clear diagnosis is the first step before any procedure is considered. For adults with a confirmed, symptomatic hydrocele, surgery can provide durable relief when observation is no longer appropriate.

At Urology Health Adelaide, assessment and treatment are planned around the diagnosis, symptom burden, general health, and practical recovery needs. A specialist discussion provides the opportunity to understand whether monitoring, aspiration in selected circumstances, or hydrocele surgery is the most suitable pathway for you.

A kidney tumour, prostate cancer diagnosis or persistent urinary obstruction can quickly turn a consultation towards the question of surgery. For suitable patients, the benefits minimally invasive surgery may offer are significant: smaller incisions, careful access to deep pelvic or abdominal structures, and a recovery plan that may be less demanding than traditional open surgery. The appropriate technique, however, depends on the condition being treated, the anatomy involved and the individual patient.

In urology, minimally invasive surgery includes laparoscopic and robotic-assisted procedures. These approaches are used for selected surgery involving the prostate, kidney, bladder and urinary tract. They are not simply smaller-incision versions of open surgery. They require specialist planning, dedicated equipment and a surgeon experienced in the relevant procedure.

Benefits minimally invasive surgery can offer in urology

The most visible difference is usually the size and number of incisions. Rather than one larger abdominal incision, laparoscopic or robotic surgery is generally performed through several small openings. A camera provides a magnified view of the operative field, while fine instruments are introduced through the remaining ports.

For robotic-assisted surgery, the surgeon controls instruments from a console beside the operating table. The system can provide high-definition three-dimensional vision and instruments designed to move with a greater range of motion than standard laparoscopic instruments. This can be particularly valuable in confined areas such as the pelvis, where critical structures are closely positioned.

For patients, these technical features may translate into less disruption to the abdominal wall and surrounding tissues. Potential benefits can include less post-operative pain, lower blood loss, a shorter hospital stay and an earlier return to normal day-to-day activity. Results vary, and these outcomes should be discussed in relation to the specific operation being considered.

Precision around important structures

Urological surgery often takes place near blood vessels, nerves, the bowel, ureters and the bladder. During robotic prostatectomy, for example, the surgeon must remove the prostate while working carefully around structures that contribute to urinary control. During kidney surgery, preserving healthy kidney tissue where appropriate may be an important aim.

Enhanced visualisation and precise instrument control can assist with meticulous dissection and reconstruction. In procedures such as pyeloplasty or ureteric reimplantation, the ability to place fine sutures accurately is central to restoring urinary drainage. The technology supports the operation, but sound surgical judgement remains the deciding factor at every stage.

Recovery and time in hospital

Many patients are understandably focused on how long they will be in hospital and when they can resume usual activities. Minimally invasive surgery may reduce the length of hospital admission compared with an open operation, although admission time differs between procedures and between patients.

Recovery is influenced by more than incision size. The complexity of the surgery, the reason for surgery, pre-existing health conditions, pain control, mobility and any post-operative complications all matter. Some patients return home after a short admission, while others require longer observation, particularly after major cancer surgery or reconstructive procedures.

A shorter hospital stay does not mean recovery is complete. Patients should still expect restrictions on heavy lifting, driving and strenuous exercise for a period advised by their surgeon. Follow-up appointments, pathology results where relevant, catheter care and monitoring for infection or other complications are all part of safe recovery.

Reduced blood loss and wound burden

Smaller access points and controlled visualisation may help reduce blood loss during selected procedures. This can lessen the likelihood of transfusion in some cases, though transfusion remains a possibility in any major operation and depends on the procedure, tissue involved and individual circumstances.

Smaller wounds may also be associated with less discomfort at the incision sites and a lower risk of some wound-related problems. Even so, port-site infection, bleeding, bruising and hernia are possible. Patients should contact their treating team if they develop increasing redness, swelling, wound discharge, fever, worsening pain or difficulty passing urine after discharge.

Where minimally invasive techniques are used

In specialist urology, minimally invasive and robotic approaches may be considered for a range of conditions. Robotic prostatectomy is commonly used for selected patients requiring surgical treatment for prostate cancer. Robotic or laparoscopic nephrectomy may be used when a kidney needs to be removed, while partial nephrectomy may be considered for selected kidney tumours where preserving functioning kidney tissue is feasible.

Robotic pyeloplasty can be used to correct a narrowing at the junction between the kidney and ureter when that obstruction affects drainage. Ureteric reimplantation may be required in selected cases where the ureter needs to be reconnected to the bladder. Some bladder operations can also be undertaken with minimally invasive techniques, depending on the condition and the extent of surgery required.

Not all procedures require robotic technology. Endoscopic surgery, performed through the natural urinary passage without external incisions, is another minimally invasive approach. It is used in many stone, bladder and prostate procedures. The best method is the one that offers an appropriate balance of safety, cancer control where relevant, functional outcome and recovery for the individual patient.

When open surgery may still be the better option

Minimally invasive surgery is not automatically the safest or most effective choice for every patient. Previous abdominal operations, extensive scar tissue, unusual anatomy, the size or location of a tumour, advanced disease or the need for a complex reconstruction can all affect the surgical plan.

In some circumstances, an open operation provides the surgeon with the most direct access and the best opportunity to complete the procedure safely. A procedure may also need to be converted from minimally invasive to open surgery if unexpected bleeding, difficult anatomy or another concern arises during the operation. This is not a failure of planning. It is a clinical decision made to protect patient safety and achieve the necessary surgical result.

For cancer surgery, the key objective is not the approach itself but appropriate removal of the cancer with the best achievable functional outcome. A smaller incision is valuable only when it does not compromise the quality or completeness of treatment.

Questions to discuss before surgery

A specialist consultation should clarify why surgery is recommended, what alternatives are available and whether a minimally invasive approach is suitable. It is reasonable to ask about the planned procedure, expected hospital stay, likely recovery restrictions, catheter or drain requirements and the complications that are most relevant to your operation.

Patients should also discuss their existing medications, particularly blood-thinning medicines, diabetes treatment and any previous surgery. Smoking status, fitness for anaesthesia and support at home can influence recovery planning. For regional patients, it is useful to consider travel arrangements and whether an overnight stay near the treating hospital may be needed before returning home.

At Urology Health Adelaide, the surgical approach is determined through specialist assessment rather than a one-size-fits-all pathway. The purpose is to select a technique that is appropriate for the condition, technically sound and aligned with the patient’s overall health and treatment goals.

If surgery has been recommended, a clear discussion of the proposed approach can replace uncertainty with practical next steps. Knowing what the operation is intended to achieve, how recovery will be managed and when to seek help after discharge allows patients and their families to prepare with confidence.

A diagnosis of localised prostate cancer does not always mean immediate treatment. For many men, the decision between active surveillance versus surgery depends on the cancer’s grade, extent, PSA results, MRI findings, life expectancy and personal priorities. The appropriate pathway is individual, and it should follow a detailed assessment by a urological specialist.

Active surveillance is a structured monitoring programme for carefully selected men with low-risk or favourable intermediate-risk prostate cancer. Surgery, most commonly radical prostatectomy, removes the prostate gland with the aim of curing cancer that remains confined to the prostate. Both approaches can be appropriate, but they serve different clinical situations.

What active surveillance involves

Active surveillance is not the same as ignoring prostate cancer or delaying care without a plan. It is an organised approach designed to avoid or postpone treatment side effects while maintaining the opportunity for curative treatment if there are signs that the cancer is progressing.

The programme usually includes regular PSA blood tests, clinical review, prostate MRI scans and repeat prostate biopsies when indicated. The timing of each test varies according to the initial cancer features, PSA trend, MRI findings and previous biopsy results.

The purpose is to identify the minority of cancers that show evidence of becoming more clinically significant. If this occurs, treatment such as surgery or radiotherapy can then be considered while the cancer remains potentially curable.

Who may be suitable for surveillance?

Active surveillance is generally considered for men whose cancer appears unlikely to cause harm in the short to medium term. Typical features may include a low PSA level, a low Gleason grade group, a small volume of cancer on biopsy and no evidence of spread beyond the prostate on imaging.

Some men with selected favourable intermediate-risk cancer may also be candidates. However, surveillance is less likely to be appropriate where biopsy findings show higher-grade disease, a substantial amount of cancer, a concerning MRI lesion or a rapidly rising PSA level.

Age alone should not determine the decision. Overall health, other medical conditions and estimated life expectancy are important because prostate cancer often behaves slowly, while treatment effects can be immediate and lasting.

Benefits and limitations of active surveillance

The main benefit of active surveillance is that many men can avoid surgery and other active treatment for years, and some may never require treatment. This can preserve quality of life while still maintaining careful oversight of the cancer.

Surveillance does require commitment. Appointments, blood tests, imaging and occasional repeat biopsy are essential parts of the process. A man who is unlikely to attend follow-up reliably may be better served by a different treatment pathway.

There can also be psychological pressure. Some people are comfortable knowing the cancer is being closely monitored. Others find the uncertainty difficult, even when their cancer has low-risk features and the chance of progression is small. Neither response is wrong. Peace of mind is a valid part of treatment planning.

It is also important to understand that a change to active treatment does not necessarily mean surveillance has failed. It may mean that new information from PSA testing, MRI or biopsy has shown that treatment is now the safer option.

When surgery may be recommended

Radical prostatectomy is an operation to remove the prostate gland and seminal vesicles. It is commonly considered for men with localised prostate cancer who are fit for surgery and have cancer features suggesting a meaningful risk of progression over time.

Surgery may be recommended when biopsy results show higher-grade cancer, imaging suggests more extensive disease, PSA levels are concerning, or a patient prefers definitive treatment rather than ongoing monitoring. It can also provide detailed pathology information about the cancer after the prostate has been removed.

For suitable patients, robotic-assisted radical prostatectomy is a minimally invasive surgical approach performed through small abdominal incisions. The technique allows precise dissection in a confined area and may support a shorter hospital stay and recovery compared with traditional open surgery. However, the choice of surgical approach should be based on the surgeon’s assessment, cancer characteristics and the patient’s overall health.

What are the trade-offs with surgery?

Surgery offers the reassurance of removing the prostate and enables the surgical specimen to be examined in detail. For men with clinically significant localised cancer, it can be an effective curative treatment.

However, radical prostatectomy is major surgery. Recovery takes time, and possible complications include bleeding, infection, blood clots, scarring, urinary leakage and changes in urinary control. There may also be changes in sexual function. The degree of risk varies according to age, baseline health, existing urinary function, cancer extent and surgical complexity.

Recovery is not identical for every patient. Some men regain urinary control quickly, while others require a longer period of pelvic floor rehabilitation. A specialist consultation should include a clear discussion of expected recovery, possible complications and the support available after surgery.

Active surveillance versus surgery: the key clinical question

The central question is not simply whether cancer is present. It is whether the cancer needs treatment now.

For a small, low-grade prostate cancer, immediate surgery may expose a man to treatment risks without offering a clear survival advantage over carefully conducted surveillance. In this setting, surveillance can be a medically sound option, not a lesser form of care.

For a higher-risk cancer, the balance changes. Delaying treatment may allow a clinically significant cancer to grow or spread, reducing the chance of cure. Surgery may therefore be recommended when the likely benefit of treatment outweighs its potential effects on quality of life.

This decision relies on more than one test. PSA is useful but can be affected by prostate size, inflammation and other factors. MRI provides detailed imaging of suspicious areas within the prostate, while biopsy confirms the cancer grade and volume. Together, these findings allow a more reliable assessment of risk.

Questions to discuss with your urologist

A consultation should give you a clear understanding of your diagnosis and the reason a particular pathway is being recommended. Useful questions include whether your cancer is low, intermediate or high risk; what your MRI and biopsy results show; how often monitoring will be required; and what findings would trigger a recommendation for treatment.

If surgery is being considered, ask about the intended surgical approach, expected hospital stay, catheter duration, recovery time and the possible effect on urinary control. It is also reasonable to ask whether other treatments should be considered as part of your overall care plan.

For patients in Adelaide and regional South Australia, a specialist urological assessment can help place PSA, MRI and biopsy results into context. At Urology Health Adelaide, treatment discussions are guided by the individual cancer features, general health and the patient’s preferences, including access to robotic and minimally invasive surgical care where appropriate.

Making a decision you can live with

There is no single answer that suits every man with localised prostate cancer. Active surveillance may be the right approach when cancer features are low risk and regular review is acceptable. Surgery may be the better choice when the cancer is more significant, monitoring is no longer appropriate, or definitive treatment aligns with the patient’s priorities.

The most useful next step is a careful discussion with a urological specialist who can explain what your results mean in practical terms, outline the expected pathway and help you make a decision with confidence.

Blood in the urine can be alarming, particularly when it leads to a diagnosis of a bladder tumour. This guide to bladder tumour resection explains the procedure most commonly used to investigate and treat these growths: transurethral resection of bladder tumour, or TURBT. It outlines what the operation involves, how to prepare, what recovery may look like and why ongoing surveillance is often necessary.

What is bladder tumour resection?

A transurethral resection of bladder tumour is performed through the urethra, the passage through which urine leaves the bladder. No cut is made in the abdomen. Under anaesthetic, a urologist passes a narrow telescope called a resectoscope into the bladder and uses specialised instruments to inspect the lining, remove visible tumour tissue and control any bleeding.

The tissue removed is sent to a pathologist. This is a central part of the procedure because a scan or camera examination alone cannot reliably determine the exact type of tumour, how deeply it has grown, or how likely it is to recur. The pathology result guides the next stage of care.

TURBT is used both to establish a diagnosis and to remove many tumours that are confined to the inner lining of the bladder. For some patients, it is the complete initial treatment. For others, it provides the information needed to plan further bladder treatment or, less commonly, more extensive surgery.

Why the pathology result matters

Bladder tumours are assessed according to their grade and stage. Grade describes how abnormal the cells appear under the microscope. Stage describes how far the tumour has grown into the bladder wall. A tumour that remains in the bladder lining or connective tissue beneath it is managed differently from one involving the bladder muscle.

The pathology report may also identify whether muscle from the bladder wall was present in the specimen. This is particularly relevant for higher-grade tumours. If the first resection was incomplete, if the tumour was high grade, or if there is uncertainty about depth, a repeat resection may be recommended within several weeks. This is not necessarily an indication that the original surgery has failed. It can be an important step in accurate staging and complete treatment.

Preparing for TURBT

Before surgery, patients usually have a consultation, review of imaging and urine tests, and an assessment of their general health and medicines. A urine infection should be treated before an operation where possible, as bacteria in the urine can increase the risk of infection after surgery.

Blood-thinning medicines require particular attention. Do not stop aspirin, anticoagulants or antiplatelet medicines without clear instructions from the surgeon, prescribing doctor or anaesthetist. The safest plan depends on why the medicine is being taken and the balance between bleeding and clotting risk.

You will receive instructions about fasting before your admission. It is also sensible to arrange transport home and practical support for the first day or two, especially if you have had a general anaesthetic. Many TURBT procedures are performed as day surgery, although an overnight stay may be appropriate depending on the extent of resection, bleeding, other medical conditions and the hospital plan.

What happens during the operation?

TURBT is generally performed under general anaesthetic, although a spinal anaesthetic may be suitable in some circumstances. Once you are anaesthetised, the surgeon examines the urethra and bladder with the telescope. The number, size, location and appearance of any tumours are recorded.

Tumour tissue is removed in controlled layers using an electrical loop or other specialised instrument. The surgeon aims to remove visible disease while obtaining adequate tissue for pathology. Small areas may be cauterised to stop bleeding. In selected cases, a medication may be placed into the bladder soon after surgery to reduce the chance of early recurrence. Whether this is appropriate depends on the appearance of the tumour, the extent of resection and the risk of bleeding or bladder injury.

At the end of the procedure, a urinary catheter may be left in place. This is a soft tube that drains urine from the bladder into a bag. It may be removed later the same day, the following morning or after a longer period if there has been a larger resection or persistent bleeding.

Recovery after bladder tumour resection

It is common to notice burning when passing urine, increased frequency and a sense of urgency for several days after TURBT. Urine may be pink or lightly blood-stained, and small clots can occur. These symptoms usually settle as the bladder lining heals.

Drinking adequate water, unless you have been advised to restrict fluids for another medical reason, can help keep urine dilute and reduce clot formation. Avoid heavy lifting, strenuous exercise and activities that worsen bleeding during the early recovery period. Your surgeon will advise when work, driving and exercise can safely resume. The timing varies according to the size and number of tumours removed, your catheter requirements and your recovery from anaesthetic.

Constipation can make bladder discomfort worse, so maintaining regular bowel habits is useful. Take prescribed pain relief as directed. If you are discharged with a catheter, the nursing team will explain catheter care and provide a plan for its removal.

When to seek urgent medical advice

Contact your treating team, attend an urgent care service or present to an emergency department if you cannot pass urine, develop heavy bleeding or large clots, have worsening lower abdominal pain, fever or chills, or feel generally unwell. These symptoms can indicate urinary retention, infection or bleeding that needs prompt assessment.

Risks and possible complications

Bladder tumour resection is a well-established urological procedure, but every operation carries risk. The likelihood and significance of complications depend on the tumour’s size and location, the depth of resection, medications and individual health factors.

Bleeding is relatively common in a mild form and usually resolves. More significant bleeding may require bladder irrigation, a catheter for longer than expected, hospital observation or occasionally a return to theatre. A urinary tract infection can occur and may require antibiotics.

A small risk of bladder perforation exists when tumour tissue is removed from the bladder wall. Minor perforations can often be managed with catheter drainage and observation. Larger or more complex injuries may require further treatment. Anaesthetic risks, temporary difficulty passing urine and scar-related narrowing of the urethra are less common considerations. These risks should be discussed in the context of your individual procedure.

Follow-up is part of the treatment

The follow-up appointment is where the pathology result and the next steps are discussed. Depending on the findings, this may involve surveillance cystoscopy, where the bladder is checked with a camera at planned intervals. Bladder tumours can recur, even after a complete resection, which is why scheduled follow-up is not optional.

Some patients benefit from treatment delivered directly into the bladder through a catheter. This may be chemotherapy or immunotherapy, selected according to tumour grade, stage and recurrence risk. Others may need additional imaging, repeat TURBT or discussion of more extensive treatment if muscle-invasive disease is identified.

There is no single follow-up schedule that suits every patient. Low-risk tumours generally require less intensive surveillance than high-grade or recurrent tumours. Clear pathology, accurate staging and regular review allow care to be tailored rather than assuming that every bladder tumour behaves the same way.

Questions to discuss with your urologist

Before surgery, it can be helpful to ask what the procedure is intended to establish or treat, whether a catheter and overnight stay are likely, and when pathology results will be available. After the result is known, ask about the tumour grade and stage, whether muscle was present in the specimen, whether repeat resection is recommended and what surveillance schedule applies to you.

Smoking is a significant risk factor for bladder cancer and recurrence. If you smoke, seeking support to stop is one practical action that can support your long-term health alongside specialist treatment.

A TURBT is often the first decisive step after a bladder tumour is found. Knowing what to expect can make the hospital process more manageable, while attending follow-up appointments gives the treating team the best opportunity to identify recurrence or progression early.

For patients facing prostate, kidney or bladder surgery, the potential robotic surgery benefits can be an important part of the treatment discussion. Robotic-assisted surgery gives the surgeon highly controlled instruments and a magnified three-dimensional view inside the body, supporting precise work through small incisions. It is not the right approach for every condition or every patient, but it has become an established option for many complex urological procedures.

What robotic-assisted surgery involves

Robotic surgery is a form of minimally invasive, or keyhole, surgery. The surgeon sits at a console in the operating theatre and controls small instruments positioned through several incisions. The robotic system does not make decisions or operate independently. Every movement is directed by the surgeon.

Compared with conventional laparoscopic instruments, robotic instruments can bend and rotate with a greater range of movement. The system also filters natural hand tremor and provides a detailed, three-dimensional surgical view. In urology, these features can be particularly useful when operating around delicate blood vessels, nerves, the urinary tract and deep pelvic structures.

Robotic-assisted techniques may be considered for procedures such as radical prostatectomy for prostate cancer, partial or radical nephrectomy for kidney tumours, pyeloplasty for a narrowing at the junction between the kidney and ureter, ureteric reimplantation and selected bladder surgery. The most appropriate operation depends on the diagnosis, the extent of disease, previous surgery, body anatomy and general health.

Robotic surgery benefits in urological procedures

The main advantage of robotic surgery is not simply that the incisions are smaller. Its value lies in combining minimally invasive access with enhanced visualisation and instrument control. This may help a specialist surgeon perform technically demanding reconstruction or cancer surgery with precision.

Smaller incisions and reduced tissue disruption

Open surgery requires a larger incision to allow direct access to the surgical site. Robotic-assisted surgery generally uses several small incisions instead. This can reduce disruption to the abdominal wall and surrounding tissue.

For suitable patients, smaller incisions may mean less wound discomfort after surgery and a lower risk of some wound-related problems. Scarring is usually less noticeable, although incision appearance should not be the deciding factor when selecting treatment for a serious urological condition.

Less blood loss in many operations

Robotic visualisation and fine instrument control can assist with careful dissection and control of blood vessels. Many robotic urological procedures are associated with lower blood loss than equivalent open operations, which may reduce the likelihood of requiring a blood transfusion.

However, blood loss varies considerably. Tumour size and location, prior operations, inflammation, medication use and the complexity of the procedure all influence the risk. A larger or more complex kidney tumour, for example, may require a different surgical approach to achieve the safest cancer and functional outcome.

A potentially shorter hospital stay and recovery period

Patients undergoing robotic surgery may leave hospital sooner than patients having open surgery, provided their recovery is uncomplicated and pain is controlled. Earlier mobilisation can also support recovery and reduce some risks associated with prolonged bed rest.

Returning home sooner does not mean returning immediately to usual activity. Recovery still requires planning. Patients may need to avoid heavy lifting, driving and strenuous exercise for a period advised by their surgeon. The recovery timeframe differs between procedures, and is often longer after major cancer surgery than after a straightforward reconstructive operation.

Precision in confined surgical spaces

The pelvis is a confined area with several structures close together. During prostate surgery, the ability to see and work clearly in this space can be valuable. Robotic instruments allow controlled movements at angles that are difficult to achieve with straight laparoscopic instruments.

For kidney surgery, a robotic approach may assist with removing a tumour while preserving as much healthy kidney tissue as possible when a partial nephrectomy is appropriate. Preserving kidney tissue can be important for long-term renal function, but it is not always feasible. The position, size and complexity of the tumour determine whether partial nephrectomy, radical nephrectomy or another treatment is recommended.

Detailed reconstruction of the urinary tract

Some urological conditions require the urinary tract to be divided and rejoined. Pyeloplasty and ureteric reimplantation are examples of reconstructive procedures where careful suturing is central to the operation.

Robotic technology can assist the surgeon with placing precise sutures and reconstructing the urinary tract through minimally invasive access. This may be particularly useful in patients with an obstruction, scarring or an injury affecting urine drainage. The expected benefit is assessed individually, as the cause and location of the problem matter.

Where robotic surgery may not be the best choice

A robotic approach should be selected because it is clinically appropriate, not because it is newer technology. Open surgery may be safer or more effective in some circumstances, including where there is extensive disease, significant scar tissue from prior surgery, a very large tumour or unexpected findings during an operation.

Some conditions can be treated without surgery at all. Depending on the diagnosis, options may include surveillance, medication, endoscopic treatment, radiotherapy or other specialist management. For cancer, the best approach is guided by tumour type, grade, stage, imaging results, kidney function and the patient’s overall medical circumstances.

Robotic surgery also requires general anaesthesia. Patients with heart, lung or other significant health conditions need an individual anaesthetic assessment before proceeding. Age alone does not determine suitability, but fitness for surgery and the likely benefit of treatment must be considered carefully.

Risks and limitations to discuss before surgery

All surgery has risks, whether it is robotic, laparoscopic or open. These may include bleeding, infection, blood clots, injury to nearby organs or structures, reactions to anaesthesia and the need for further treatment. A procedure may occasionally need to be converted from robotic to open surgery if this offers a safer way to complete the operation.

The specific risks also depend on the procedure. Prostate surgery can affect urinary control, while kidney surgery may affect kidney function depending on the amount of tissue removed and the condition of the other kidney. Bladder and ureteric procedures can involve stents, catheters or drains during the early recovery period.

A realistic discussion should cover the intended purpose of surgery, alternatives, possible complications and what recovery is likely to involve. It should also address the results that matter most for the individual patient, including cancer control where relevant, relief of obstruction, preservation of kidney function and return to daily activities.

The importance of surgical experience

Technology is only one part of the operation. The surgeon’s training, judgement and experience with the specific procedure remain central to safe care. Robotic surgery involves a learning curve, and complex urological cases require thoughtful planning before the patient enters the operating theatre.

At Urology Health Adelaide, robotic and minimally invasive techniques are considered as part of a broader specialist assessment. Imaging, pathology, symptoms, medical history and treatment priorities are reviewed to determine whether surgery is needed and, if so, which approach is most suitable.

Patients should feel comfortable asking why a robotic procedure has been recommended, whether there are reasonable alternatives, how often their surgeon performs the operation and what support will be needed after discharge. Clear answers help patients make informed decisions rather than choosing an approach based on the technology alone.

If robotic surgery is being considered for a urological condition, the next useful step is a specialist consultation that focuses on your diagnosis, treatment goals and the procedure most likely to offer a safe and durable result.

A raised PSA result does not, by itself, diagnose prostate cancer. PSA can rise for several reasons, including benign prostate enlargement, inflammation, infection and recent urinary procedures. Prostate imaging helps a urologist put that result into context, identify whether an area needs closer assessment and plan the next step with greater precision.

For many men, imaging reduces uncertainty before a biopsy is considered. For others with a confirmed diagnosis, it helps determine whether cancer appears confined to the prostate or has spread beyond it. The right scan depends on the clinical question, PSA level, examination findings, previous biopsy results and the type of treatment being considered.

Why prostate imaging may be recommended

Imaging is usually requested after a discussion with a GP or urologist about symptoms, PSA testing and prostate examination. Some men have urinary symptoms such as a weak stream, urgency or getting up frequently overnight. These symptoms are common with benign prostate enlargement and do not necessarily indicate cancer, but they still require appropriate assessment.

A scan may be recommended when PSA is persistently elevated, rising over time, or does not align with the estimated prostate size. It may also be useful if a prostate examination identifies an area of firmness or irregularity, or if a previous biopsy was negative but clinical suspicion remains.

When prostate cancer has already been diagnosed, imaging contributes to staging. Staging assesses the size and local extent of the tumour and looks for evidence of disease in lymph nodes, bones or other areas. This information supports decisions between active surveillance, surgery, radiation treatment or other management pathways.

Multiparametric MRI for prostate imaging

Multiparametric magnetic resonance imaging, usually called mpMRI, is now a central part of contemporary prostate assessment. It produces detailed images of the prostate and combines several imaging sequences to assess tissue characteristics, not simply anatomy.

An mpMRI can identify areas that are more likely to contain clinically significant prostate cancer. Radiologists report these areas using a scoring system known as PI-RADS, which helps indicate how suspicious a finding appears. A higher score does not confirm cancer, but it may support proceeding to a targeted biopsy.

MRI also provides useful information about prostate size and anatomy. This can help distinguish a PSA elevation associated with a larger benign prostate from one that warrants further investigation. It may show changes related to inflammation or previous treatment, although appearances can overlap and must be interpreted with the full clinical picture.

What an MRI can and cannot tell us

A reassuring MRI may allow some men to avoid an immediate biopsy, particularly when PSA density and other clinical factors are low risk. However, no test is perfect. Small or low-grade cancers can be missed, and a normal or low-suspicion MRI does not automatically rule out cancer.

Conversely, an abnormal MRI does not always mean cancer is present. Benign enlargement, inflammation and scarring can sometimes produce suspicious appearances. A urologist considers the MRI report alongside PSA trends, examination findings, family history, age and overall health before making a recommendation.

MRI does not involve ionising radiation. The scan commonly takes around 30 to 45 minutes and requires the patient to remain still in the scanner. Claustrophobia, certain implanted medical devices and reduced kidney function may affect whether MRI or contrast administration is suitable. These issues can be discussed before the appointment.

MRI-guided and transperineal biopsy planning

When biopsy is necessary, prostate MRI can improve how it is performed. Rather than taking samples only from standard areas of the prostate, suspicious MRI regions can be specifically targeted. This is often achieved with MRI-ultrasound fusion, where MRI images are matched with live ultrasound during the procedure.

A transperineal prostate biopsy accesses the prostate through the skin between the scrotum and anus. It can sample both targeted MRI lesions and systematic areas of the prostate. This approach is increasingly used because it provides thorough sampling and has a lower risk of serious infection than biopsy through the rectum.

A biopsy remains the definitive way to confirm prostate cancer and determine its grade. Imaging guides the procedure, but pathology from the tissue samples establishes the diagnosis. The pathology report helps determine whether treatment is needed and, if so, how promptly.

PSMA PET-CT and staging prostate cancer

PSMA PET-CT is a specialised scan used most often after prostate cancer is confirmed. It uses a tracer that attaches to prostate-specific membrane antigen, a protein commonly expressed on prostate cancer cells. The PET component identifies areas taking up the tracer, while CT provides anatomical detail.

This scan can be particularly valuable for men with intermediate- or high-risk prostate cancer, where there is a greater possibility of disease outside the prostate. It may identify small lymph node deposits or bone involvement that would not be visible on conventional imaging. The findings can alter the treatment plan, including whether surgery remains appropriate or whether another treatment approach should be considered.

PSMA PET-CT may also be used when PSA rises after previous treatment for prostate cancer. In this setting, it can help locate recurrent disease and guide further management.

Like all imaging, PSMA PET-CT has limitations. Very small-volume disease may not be detected, and tracer uptake can occasionally occur in non-cancerous conditions. A positive finding is interpreted by the treating team in light of pathology, PSA behaviour and other scan results. Access and Medicare eligibility can also vary according to the clinical indication.

The role of ultrasound, CT and bone scans

Ultrasound remains an important practical tool in urology. Transrectal ultrasound may be used during biopsy to visualise the prostate and guide needle placement. On its own, however, it is less accurate than mpMRI for identifying suspicious cancer within the gland.

CT and conventional bone scans still have a role in selected cases, particularly where more advanced disease is suspected or where PSMA PET-CT is not appropriate or available. CT is useful for assessing anatomy and larger lymph nodes, while a bone scan looks for patterns consistent with bone spread. They do not replace MRI for local assessment of the prostate.

The choice between tests is not a matter of ordering every available scan. More imaging can create incidental findings that require follow-up and may add cost, radiation exposure or anxiety without changing treatment. A targeted investigation plan is generally more useful than a broad screening approach.

Preparing for your scan and appointment

Preparation instructions differ between imaging providers and scan types. MRI may involve screening for metal implants, pacemakers, prior surgery and kidney problems. For PSMA PET-CT, patients are usually given specific instructions about hydration and timing. Follow the radiology provider’s directions carefully and bring details of previous PSA results, biopsy reports and imaging where available.

At the urology consultation, useful questions include what the scan is intended to clarify, whether biopsy is still likely to be required, and how the result could change management. It is also reasonable to ask whether a finding is likely to affect the choice between surveillance, surgery or other treatment.

For men considering robotic prostatectomy, accurate staging is particularly relevant. Imaging cannot guarantee whether cancer is fully confined to the prostate, but it helps inform surgical planning and a realistic discussion about the expected benefits and limitations of treatment.

A measured next step after an abnormal PSA

An abnormal PSA result deserves proper follow-up, but it should not be treated as a diagnosis. Repeat testing, urine assessment, prostate examination, MRI and biopsy each have a different role. The appropriate sequence depends on the individual circumstances rather than a single PSA number.

Specialist assessment provides a clear pathway from an uncertain test result to an informed decision. For men in Adelaide and regional South Australia, discussing prostate imaging with an experienced urologist can help ensure that investigations are purposeful, results are interpreted in context and any treatment plan is matched to the disease actually present.

A new lump in a testicle is not something to watch for a few weeks and hope will settle. The warning signs testicular cancer may cause are often painless and can be subtle, which is why a prompt medical assessment matters. Most scrotal changes are not cancer, but distinguishing a harmless cause from a condition requiring treatment needs examination and, usually, an ultrasound.

Testicular cancer is less common than prostate, bladder or kidney cancer, but it is one of the more common cancers affecting younger adult men. It can occur at any age, with many diagnoses made between the late teens and early forties. When identified early, treatment outcomes are generally very good.

The main warning signs of testicular cancer

The most common sign is a new lump, firm area or enlargement within one testicle. A cancerous lump is often painless, although some men notice a dull ache or a feeling that the testicle has become heavier. It may feel different from the other side, but the key change is usually a distinct area of firmness or a gradual increase in size.

Other changes that warrant review include swelling of the scrotum, a persistent feeling of heaviness, or an ache in the lower abdomen or groin. Occasionally, fluid can collect around the testicle, causing the scrotum to appear enlarged. This may be caused by a range of conditions, but it should not be assumed to be benign without assessment.

Less commonly, testicular cancer can cause breast tenderness or enlargement. Some tumours produce hormones that can lead to these changes. Back pain, persistent abdominal discomfort, cough, chest pain or unexplained weight loss are not usual early symptoms, but can occur if cancer has spread beyond the testicle. These symptoms have many possible causes, yet should be discussed with a doctor, particularly when they occur alongside a testicular lump or swelling.

What a concerning lump can feel like

A testicular lump may feel like a small hard pea, a firm irregular patch, or a general hardening of part of the testicle. It is often found while showering or dressing rather than because it causes pain. The normal structures at the back and upper part of a testicle, including the epididymis, can feel lumpy or rope-like. This is one reason self-checking should prompt medical review rather than self-diagnosis.

A lump in the scrotal skin is different from a lump arising from the testicle itself. So is a swollen vein, which may feel like a soft cluster of cords. These differences can be difficult to judge accurately at home. A GP or urologist can examine the area and arrange the appropriate investigation.

Not every scrotal change is cancer

Several common conditions can cause pain, swelling or a lump around the testicle. Infection or inflammation of the epididymis can cause tenderness, swelling and sometimes urinary symptoms. A hydrocele is fluid around the testicle and often creates a smooth, painless swelling. A varicocele is an enlargement of scrotal veins, more often on the left side, and may cause a dragging discomfort.

Cysts, hernias and previous injury may also change the feel or appearance of the scrotum. These conditions need different management, and some need treatment in their own right. The practical point is not to try to determine the cause by symptoms alone. Any new or persistent testicular change should be examined.

When pain needs urgent assessment

Testicular cancer is commonly painless, but pain does not rule it out. Sudden, severe testicular pain is more concerning for testicular torsion, where the blood supply to the testicle twists. This is a surgical emergency and requires immediate assessment at an emergency department.

Seek urgent care on the same day for sudden severe scrotal pain, pain with nausea or vomiting, rapid swelling, redness, fever, or a testicle that appears higher than usual. Infection can also become serious if untreated. It is safer to be assessed promptly than to wait for a routine appointment when symptoms start suddenly or are severe.

Risk factors that can increase concern

Most men diagnosed with testicular cancer do not have a clear cause. However, risk is higher in men who had an undescended testicle, even if it was corrected in childhood. A previous testicular cancer and a close family history can also increase risk.

Having a risk factor does not mean cancer will develop, and having no risk factors does not exclude it. Regular awareness of what is normal for your testicles is reasonable, particularly for men with a history of an undescended testicle. There is no need for intensive or anxious checking. A brief check after a warm shower can help you notice a genuine new change.

How testicular cancer is investigated

The first step is a clinical assessment. Your GP will take a history, examine the testicles and groin, and usually arrange a scrotal ultrasound. Ultrasound is painless, does not use radiation, and can determine whether a lump is within the testicle or outside it. This distinction is clinically significant because a solid lump within the testicle requires urgent urological review.

If cancer is suspected, blood tests may be used to measure tumour markers. These are substances that can be raised in some testicular cancers, although normal results do not rule cancer out. Further imaging may be arranged to assess lymph nodes and other areas of the body if required.

A needle biopsy is not generally used for a suspected testicular tumour because it may affect the usual treatment pathway. Where imaging strongly suggests cancer, the standard initial operation is removal of the affected testicle through an incision in the groin, known as radical inguinal orchidectomy. The removed tissue is examined to establish the precise tumour type and guide any further care.

Treatment is tailored to the cancer and the person

For many men, surgery to remove the affected testicle is the only treatment required. Depending on the pathology results and staging, some patients may need surveillance with planned scans and blood tests, while others may be advised to have chemotherapy, radiotherapy or further surgery. The appropriate approach depends on the type of cancer, whether it has spread, tumour marker levels and individual circumstances.

Losing one testicle does not usually affect testosterone production, sexual function or the ability to father children when the other testicle is healthy. Fertility can be affected by the cancer itself or by subsequent treatment, however. Sperm banking should be discussed before treatment where future fertility is a consideration. A testicular prosthesis may also be discussed for patients who wish to consider it.

When to make an appointment

Arrange a GP appointment promptly if you notice a new lump, firm area, unexplained enlargement, persistent heaviness or ongoing scrotal discomfort. Do not wait for pain to develop. If ultrasound or examination identifies a suspicious finding, timely referral to a urologist allows the diagnosis and treatment plan to proceed without unnecessary delay.

Urology Health Adelaide provides specialist assessment and surgical management for scrotal conditions and urological cancers. For a newly discovered testicular lump, the most useful next step is a prompt examination and ultrasound, followed by specialist review when indicated. Early assessment provides clarity, and when treatment is needed, it allows care to begin at the right time.